{"@type": "dcat:Dataset", "accessLevel": "public", "accrualPeriodicity": "R/P1Y", "bureauCode": ["009:10"], "contactPoint": {"@type": "vcard:Contact", "fn": "Division of Drug Information", "hasEmail": "mailto:druginfo@fda.hhs.gov"}, "description": "Thioridazine Hydrochloride is a generic prescription drug available as 10 mg film-coated tablets for oral use. Manufactured by Chartwell RX, LLC under application ANDA088131, it belongs to the phenothiazine class and is now discontinued. This information was generated using AI and is provided for informational and research purposes only.", "distribution": [{"@type": "dcat:Distribution", "description": "\n        Access the FDA dataset for Thioridazine hydrochloride \u2014 ANDA 088004 submitted by Mylan Institutional LLC\n    ", "downloadURL": "https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=088004", "mediaType": "text/html", "title": "Thioridazine hydrochloride"}], "identifier": "ANDA088004", "issued": "2016-09-16", "keyword": ["drug-safety", "fda", "health-care", "drug-information", "medications"], "landingPage": "https://www.fda.gov/drugs", "license": "https://open.fda.gov/license", "modified": "2025-03-17", "programCode": ["009:002"], "publisher": {"@type": "org:Organization", "name": "U.S. Food and Drug Administration"}, "theme": ["FDA"], "title": "Thioridazine hydrochloride"}